Guideline for testing for SARSCoV2 in patients with suspected COVID-19

SARS-CoV-2, the agent responsible for COVID-19, causes a self-limited influenza-like illness in the majority of cases but can progress to severe disease and death in a small proportion of patients. For most patients, testing for COVID-19 does not change clinical decisions or recommended
therapy but has significant infection control implications, particularly if the patient will be admitted. Currently the only approved testing method for viral detection is RT-PCR. Antibody testing may be useful for surveillance and detection of immunity, but should not be used to test for active viral infection. This document aims to help clinicians determine when testing for
viral infection (by RT-PCR) is indicated.

Guidance for Cardiac Electrophysiology During the Coronavirus (COVID-19) Pandemic from the Heart Rhythm Society COVID-19 Task Force
Size: 611 KB